TEVA

TEVA EBITDA Margin

14.98%TTM

Period ending:

TEVA FY EBITDA Margin%
TEVA FY EBITDA Margin44.44%-81.32%
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

TEVA ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 40 observations from Dec 31, 1985 to Dec 31, 2025.

Teva Pharmaceutical Industries Limited American Depositary Shares EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
18.2013%
26.7831%
9.8328%
-6.1977%
27.768%
27.6847%
26.2806%
0.9865%
-69.1535%
13.2219%
32.2664%
29.4692%
15.7822%
19.1072%
23.258%
29.9299%
17.3034%
10.3293%
25.4571%
30.0547%
29.6168%
29.0275%
30.9028%
20.8052%
23.375%
26.8705%
26.1925%
23.5214%
20.2164%
18.138%
20.5482%
22.8518%
21.4343%
17.9002%
20.1467%
16.079%
15.7595%
14.3534%
17.4785%
16.886%

Compare ebitda margin

All TEVA financial metrics · TEVA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.